Latest filing published 20 Nov 2023 for Acer Therapeutics Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Donald Joseph discloses dealings in Acer Therapeutics Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 24 July 2020 and the latest from 17 November 2023.
Every open-market trade on record is a purchase: 1 purchase worth €43k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 20 November 2023, reports a transaction in Acer Therapeutics Inc. The clock since the last published purchase (28 July 2020) now reads 2,279 days. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations